Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 119
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00526396 | STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study | ||
| NCT06905145 | Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis | ||
| NCT04290299 | Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre Archive | ||
| NCT07027046 | Application of da Vinci SP for Endometrial Cancer Surgical Staging | ||
| NCT07267780 | Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases. | ||
| NCT00345059 | The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer | ||
| NCT02624128 | Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck | ||
| NCT07213570 | STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer | ||
| NCT01628211 | Second Look Laparoscopy in Colorectal Cancer | ||
| NCT04129281 | Active Surveillance Versus Surgery in Thyroid Papillary Microcarcinoma | ||
| NCT06341764 | Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma | ||
| NCT00401609 | G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients | ||
| NCT01405586 | MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer | ||
| NCT04893785 | A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM) | ||
| NCT01359956 | Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma | ||
| NCT04595032 | MAnagement of METastatic Disease in Campania (MAMETIC) | ||
| NCT06887244 | Effectiveness of Nurse Tele-consultation on the Quality of Elective Colonoscopy, Procedure-related Anxiety, and Financial Toxicity | ||
| NCT01644825 | Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer | ||
| NCT01481545 | Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer | ||
| NCT00540800 | BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer | ||
| NCT00660842 | Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer | ||
| NCT00403429 | MITO-6: Capecitabine in Platinum Resistant Ovarian Cancer | ||
| NCT06270602 | The ONCOCAMP Study | ||
| NCT02069067 | Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated | ||
| NCT01706120 | Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab | ||
| NCT00330746 | CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer | ||
| NCT01718873 | Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer | ||
| NCT04416672 | Validation of the Italian Version of the PRO-CTCAE | ||
| NCT02364791 | A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures | ||
| NCT00401635 | END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin | ||
| NCT01649674 | Comparison of Bowel Cleansing Regimens Prior to Colonoscopy | ||
| NCT06886282 | Spatial RadiomIcs and TRanscriptomics to the DIscovery of the Cross-link Between Colon Cancer and ChrOnic Kidney Disease | ||
| NCT07290894 | Pembrolizumab Plus Lenvatinib in Vulvar Cancer Patients: MITO VULVA-01 | ||
| NCT00401427 | HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer | ||
| NCT04893356 | Impact of O6-methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and MGMT Expression on Dacarbazine Treated Sarcoma Patients (MGMT) | ||
| NCT07522697 | Inavolisib for PIK3CA Mutated Advanced Endometrial Cancer: MITO END-4 | ||
| NCT05733793 | Molecular Data and Their Correlations With Clinical Outcomes in Gynecological Cancer Patients. | ||
| NCT04139772 | Docetaxel or Hormone Therapy as Second Line Treatment in Patients With Asymptomatic or Oligosymptomatic Metastatic Castration-resistent Prostate Cancer (mCRPC) Progressing After Abiraterone or Enzalutamide. | ||
| NCT00997009 | Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical Cancer | ||
| NCT00401674 | MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer | ||
| NCT02381054 | Translation, Cross-cultural Adaptation and Validation of PRO-CTCAE for Italian-speaking Cancer Patients | ||
| NCT01656551 | MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer | ||
| NCT02408536 | Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer | ||
| NCT06866093 | The Study is Observational and Retrospective: Lifestyle, BMI and Activity Physical. | ||
| NCT02619435 | Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer | ||
| NCT01061619 | Pathway to Diagnosis of Ovarian Cancer | ||
| NCT02618850 | PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment | ||
| NCT04129255 | Octreotide LAR in the Induction of Immunologic Response in NENs Patients | ||
| NCT06880523 | STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma | ||
| NCT02786875 | Diet, Exercise and Vitamin D in Breast Cancer Recurrence |
